» Articles » PMID: 18057897

Incidence of Status Epilepticus in Southern Europe: a Population Study in the Health District of Ferrara, Italy

Overview
Journal Eur Neurol
Specialty Neurology
Date 2007 Dec 7
PMID 18057897
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The epidemiologic features of status epilepticus (SE) are still in the course of definition.

Methods: We carried out an intensive survey of multiple sources of case material in the resident population of the health district of Ferrara, Italy, in 2003. Information was collected on age, gender, duration, seizure type and etiology of SE.

Results: The age- adjusted annual incidence rate of SE was 27.2/100,000 (95% CI = 19.4-36.9) and it was higher in men (41.7/100,000, 95% CI = 26.9-61.7) than in women (12.3/100,000, 95% CI = 6.9-20.4). The incidence was higher in the elderly (older than 60 years, 39.2/100,000) than in younger adults in the age group 20-59 years (14.7/100,000). The age-specific incidence showed a bimodal distribution peaking in the youngest (0-4 years) and in the oldest age group (75+ years). Cerebrovascular disease was the most frequent etiologic factor (45%). Epilepsy had previously been diagnosed in 40% of the patients. The case fatality was 5%.

Conclusions: The study found a higher incidence of SE than that expected on the basis of the previous European studies suggesting that the risk of SE in southern Europe is higher and more similar to that estimated in population studies in the United States. The case fatality was lower than that reported in previous South-European population studies despite the similar clinical features of the patients. Indirect evidence suggests that several factors related to the SE management could have positively influenced the outcome.

Citing Articles

Convulsive Status Epilepticus in Indonesia.

Husna M, Nurlaela S, Pradana B, Aushi F, Atdisuramad P Balkan Med J. 2024; 41(6):507-510.

PMID: 39077897 PMC: 11589212. DOI: 10.4274/balkanmedj.galenos.2024.2024-3-8.


Mortality, and life expectancy in Epilepsy and Status epilepticus-current trends and future aspects.

Trinka E, Rainer L, Granbichler C, Zimmermann G, Leitinger M Front Epidemiol. 2024; 3:1081757.

PMID: 38455899 PMC: 10910932. DOI: 10.3389/fepid.2023.1081757.


Epidemiology, real-world treatment and mortality of patients with status epilepticus in Germany: insights from a large healthcare database.

Mevius A, Joeres L, Gille P, Molzan M, Foskett N, Wilke T Brain Commun. 2023; 5(3):fcad145.

PMID: 37180995 PMC: 10174205. DOI: 10.1093/braincomms/fcad145.


Status Epilepticus in Older Adults: Diagnostic and Treatment Considerations.

Osman G, Hocker S Drugs Aging. 2023; 40(2):91-103.

PMID: 36745320 DOI: 10.1007/s40266-022-00998-z.


Hippocampal glucocorticoid receptors modulate status epilepticus severity.

Kraus K, Nawreen N, Godale C, Chordia A, Packard B, LaSarge C Neurobiol Dis. 2023; 178:106014.

PMID: 36702319 PMC: 10055427. DOI: 10.1016/j.nbd.2023.106014.